Cargando…

Stimulating severe COVID-19: the potential role of GM-CSF antagonism

Detalles Bibliográficos
Autores principales:	Leavis, Helen L, van de Veerdonk, Frank L, Murthy, Srinivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635456/ https://www.ncbi.nlm.nih.gov/pubmed/34863335 http://dx.doi.org/10.1016/S2213-2600(21)00539-7

Ejemplares similares

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Managing secondary fungal infections in severe COVID-19: how to move forward?
por: Verweij, Paul E, et al.
Publicado: (2022)

A role for interleukin-1 receptor antagonism in severe COVID-19?
por: Tattersall, Rachel S, et al.
Publicado: (2021)

An update on GM-CSF and its potential role in melanoma management
por: O Dillman, Robert
Publicado: (2020)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Antifungal immune responses: emerging host–pathogen interactions and translational implications
por: Kumar, Vinod, et al.
Publicado: (2018)

When Wnts antagonize Wnts
por: Weidinger, Gilbert, et al.
Publicado: (2003)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

IL-6 blockade for COVID-19: a global scientific call to arms
por: Murthy, Srinivas, et al.
Publicado: (2021)

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

Role of GM-CSF in lung balance and disease
por: Chen, Yingzi, et al.
Publicado: (2023)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease
por: Cook, Andrew D, et al.
Publicado: (2001)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update
por: Lotfi, Noushin, et al.
Publicado: (2019)

A Review of GM-CSF Therapy in Sepsis
por: Mathias, Brittany, et al.
Publicado: (2015)

Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fcγ-receptors
por: Ottonello, L, et al.
Publicado: (2001)

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
por: Bonaventura, Aldo, et al.
Publicado: (2020)

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
por: Thwaites, Ryan S, et al.
Publicado: (2021)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
por: Malek, Alexandre E.
Publicado: (2021)

Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study
por: Temesgen, Zelalem, et al.
Publicado: (2020)

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
por: Patel, Jatin, et al.
Publicado: (2023)

MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer
por: Ma, Ning, et al.
Publicado: (2017)

GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?
por: Mishra, Abhishek, et al.
Publicado: (2020)

GM-CSF: Orchestrating the Pulmonary Response to Infection
por: McCormick, Thomas S., et al.
Publicado: (2022)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Induced Severe Atypical Rash in a Patient of Non-Hodgkin's Lymphoma
por: Singh, Gautam Kumar, et al.
Publicado: (2022)

GM-CSF targeting in COVID-19: an approach based on fragile foundations
por: Kohler, Katharina, et al.
Publicado: (2023)

Involvement of a phospholipase D in the mechanism of action of granulocyte-macrophage colony-stimulating factor (GM-CSF): priming of human neutrophils in vitro with GM-CSF is associated with accumulation of phosphatidic acid and diradylglycerol
Publicado: (1990)

Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody
por: Papp, K.A., et al.
Publicado: (2018)

The Stimulation of Macrophages by Systematical Administration of GM-CSF Can Accelerate Adult Wound Healing Process
por: Zhang, Jing, et al.
Publicado: (2022)

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease
por: Potter, Huntington, et al.
Publicado: (2021)

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?
por: Zhang, Shen-Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eqaldf1vcfuq23qh9dr0dnsunc